SPECIAL NOTICE: 36C24925Q0350 Description: NOTICE OF INTENT TO AWARD A SOLE SOURCE The Department of Veterans Affairs intends to issue sole-source firm-fixed priced contract to B2H Consulting Group (B2HCG), 2039 Morgan Ave N, Stillwater, MN 55082. In accordance with Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i) and on behalf of the James H. Quillen VA Medical Center, Network Contracting Office (NCO) 9 intends to negotiate on a sole source basis with B2HCG. The rationale basis for the sole source acquisition is that B2HCG is the only responsible source that can provide the original equipment manufacturer (OEM) parts and products for the ACIST equipment. The letter from the manufacturer shall state that the contractor is an Original Equipment Manufacturer (OEM) authorized dealer, authorized distributor or authorized reseller for the proposed equipment/system such that OEM warranty and service are provided and maintained by the OEM. All software licensing, warranty and service associated with the equipment/system shall be in accordance with the OEM terms and conditions. The maintenance shall be provided by original equipment manufacturer (OEM)-certified technicians and shall use only OEM-approved replacement parts and proprietary software. The NAICS code is 339112 and has a size standard of 1,000 employees for this procurement. Period of Performance: 07/17/2025 09/30/2025 This requirement includes the purchase of the ACIST CVI Standard Contrast Dye Injector System with 7-year Warranty and Preventative Maintenance. This purchase will maintain the standardization of equipment currently in use at the James H Quillen VA Medical Center. The CVi System and associated consumable kits is the only automated angiographic injector system on the market that provides the following specific design features: Variable rate control allows for precise contrast delivery and reduces contrast volume delivery by 22% over hand manifold. Multi-use syringe facilitates the use of a single bottle of contrast in up to 6 patient procedures which reduces set-up time between cases. Air Column Detect (ACD) sensor is designed to aid the user in detection of air columns in the injection tubing to avoid injecting air and causing an air embolism. Manifold is designed to prevent reverse flow by automatically closing when fluid flow stops. Pneumatic hand controller enables ergonomic contrast delivery. Automatic hemodynamic monitoring capability. There is no comparable/similar type of equipment that performs to these standards. Standardized Contrast injection: The ACIST CVi System standardizes cardiovascular angiographic imaging across all procedures, from small injections in the coronaries to large volumes in the ventricles and peripheral vasculature. It provides advanced technology that physicians and staff rely on for consistency and safety. Patient Safety: CVi Contrast System helps to reduce the incidence of contrast-induced nephropathy (CIN); also called acute kidney injury (AKI). Lowering the contrast dose administered to the patient is one option to help reduce AKI. When compared to manual injection, automated contrast injection can: Decrease contrast dosage Reduce CIN incidence by 15%, based on meta analysis Use of ACIST CVi has been shown to achieve a median contrast volume of 17.9 mL per procedure using an ultra-low dose protocol. The ACIST CVi System has built-in features that provide continuous automated monitoring of all critical systems functions, including an air detect sensor that protects patients from air injection. Improving safety for physicians and staff: The CVi provides precise control of contrast injections for interventional and diagnostic angiographic procedures. Physicians and patients benefit from fast, safe procedures: Compared to hand injections, the AngioTouch® hand controller results in fewer images needed, using less fluoroscopy, and reducing radiation exposure for physicians and staff. It also enables the physician to take a step back from the radiation source, further reducing exposure. Innovative system design is easy to use and simple to operate, eliminating hand injections and reducing wrist and back strain associated with manual injections. ACIST has intellectual property rights for this equipment which includes patents, trademarks, and copyrights. Due to the proprietary design of the CVi System, ACIST (and B2H Consulting Group LLC working at ACIST s direction as its SDVOSB reseller) is the sole proprietor for the service and repair of ACIST products. Vendor performance expectations: The vendor will be at the James H Quillen VA to set up equipment and train staff and physicians on the ACIST CVi Contrast Dye Injector System once the equipment arrives at the hospital and ready to be install once BioMed has reviewed the equipment. The vendor site visit will be set up with the vendor once the equipment has arrived. Training will take place in the Cath Lab, or in other designated location, once the vendor has installed the equipment in the room. Items List: Part Number Item Description Quantity 019398 1) ACIST CVi Standard Contrast Dye Injector System w/ 7-year Warranty and Preventative Maintenance 2 EA Other important considerations: Capability statement /information sought: Response to this announcement shall not to exceed 10 pages and should include the following information: (1) A tailored capability statement indicating the firm s ability to provide a product and related services; (2) The respondents UEI number, organization name, address, point of contact, and size and type of business (e.g. SDVOSB/VOSB, etc.) pursuant to the applicable NAICS code and whether they are U.S. or foreign owned; and (4) Information should be provided electronically in an Adobe PDF format. Respondents who submit proprietary data shall clearly mark the data with appropriate markings. The Government will not pay for any information submitted as a result of this notice. This notice of intent is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to the requirement and submit quotations with the subject line "Special Notice # 36C24925Q0350 by 3:00 p.m. on 07/16/2023 to [email protected]. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses received to this notice is solely within the discretion of the Government. Disclaimer and Important Notes. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). Contracting Office Address: Department of Veterans Affairs Network Contracting Office 9 1639 Medical Center Parkway, 204 Murfreesboro, TN 37129 Government Point of Contact: Elizabeth Trimm Contracting Officer [email protected]